PHARMACY PLUS HEALTH LIMITED
Get an alert when PHARMACY PLUS HEALTH LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-12-31 (in 7mo)
Last filed for 2025-03-31
Confirmation statement due
2027-04-10 (in 11mo)
Last made up 2026-03-27
Watchouts
Cash
—
Latest balance sheet
Net assets
-£22M
-53.2% lowest in 3 filed years
Employees
204
-21.8% vs 2024
Profit before tax
-£8M
+46.8% vs 2024
Watchouts
Facts from the Companies House register and the latest accounts — not a rating
-
Audit opinion: Qualified
Latest auditor's report carried a non-clean opinion.
Net assets
4-year trend · vs Health Care median
Accounts
4-year trend · latest reflected 2025-03-31
| Metric | Trend | 2023-03-14 | 2023-03-15 | 2024-03-31 | 2025-03-31 |
|---|---|---|---|---|---|
| Turnover | — | — | £26,207,259 | £23,402,882 | |
| Operating profit | — | — | -£11,539,191 | -£4,235,303 | |
| Profit before tax | — | — | -£14,282,369 | -£7,594,780 | |
| Net profit | — | — | -£14,282,369 | -£7,594,780 | |
| Cash | £1 | — | — | — | |
| Total assets less current liabilities | £1 | — | -£593,762 | -£8,928,140 | |
| Net assets | £1 | — | -£14,282,368 | -£21,877,148 | |
| Equity | £1 | £1 | -£14,282,368 | -£21,877,148 | |
| Average employees | 4 | — | 261 | 204 | |
| Wages | — | — | £5,853,067 | £5,319,362 |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-03-14 | 2023-03-15 | 2024-03-31 | 2025-03-31 |
|---|---|---|---|---|---|
| Operating margin | — | — | -44.0% | -18.1% | |
| Net margin | — | — | -54.5% | -32.5% | |
| Return on capital employed | — | — | 1943.4% | 47.4% | |
| Interest cover | — | — | -4.21x | -1.26x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- Forrester Boyd Robson Limited
- Audit opinion
- Qualified
- Going concern
- Affirmed
“In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate. Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the Company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.”
Group structure
- PHARMACY PLUS HEALTH LIMITED · parent
- Headingley Projects Limited 100%
- Missionstart Limited 100%
- Insightwave Limited 100%
- Presentornot Limited 100%
- Averagedream Limited 100%
- Living Care Limited 100%
- Living Care Pharmacy Limited 100%
- Living Care Pharmacy (East Leeds) Limited 100%
- Living Care Pharmacy (Wakefield) Limited 100%
- Living Care Pharmacy (South Leeds) Limited 100%
- Living Care Pharmacy (Chapeltown) Limited 100%
- Living Care Pharmacy (Ilkley) Limited 100%
- Living Care Pharmacy (Rockwell) Limited 100%
- Living Care Pharmacy (Hornsea) Limited 100%
- Living Care Pharmacy (North Leeds) Limited 100%
- TPG (Normanton) Ltd 100%
- TPG (Bramley) Ltd 100%
- TPG (Tieve Tara) Ltd 100%
- TPG (Scarborough) Ltd 100%
- TPG (Flamborough) Ltd 100%
- TPG (Bridlington) Ltd 100%
- TPG (LSP) Limited 100%
- TPG (Oatland) Limited 100%
- TPG (Trinity) Limited 100%
- TPG (Dringhouses) Limited 100%
- TPG (Fulford) Limited 100%
- TPG (Middleton) Limited 100%
Significant events
- “Subsequent to the balance sheet date, the Company concluded a formal legal process relating to a claim initiated concerning the acquisition of the pharmacy estate with Pharmacy Plus Health Limited. The legal process was concluded in full on 19 September 2025.”
- “It is considered that a contingent asset has arisen in Pharmacy Plus Health Limited due to the formal derecognition of £367,000 of aged creditors and £5,000,000 of exceptional income, resulting from a legal process that took place in FY26. The aged creditors are deemed to have been settled in full. The asset will be recognised once the date of the agreement is certain in FY26.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
3 active · 1 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| LEE, Daniel Mark | Director | 2022-10-26 | May 1970 | British |
| PASSMORE, Sarah, Dr | Director | 2022-10-26 | Oct 1979 | British |
| TOLLEFSON, Matthew Thomas | Director | 2022-10-26 | Oct 1990 | British |
Show 1 resigned officer
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| LESTNER, Jason Elliot | Director | 2023-03-16 | 2024-04-30 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Hubrx Ltd | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2022-10-26 | Active |
Filing timeline
Last 15 of 15 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-04-10 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2026-03-31 | AA | accounts | Accounts with accounts type full | |
| 2025-03-31 | AA | accounts | Accounts with accounts type total exemption full | |
| 2025-03-28 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-12-18 | MR05 | mortgage | Mortgage charge part both with charge number | |
| 2024-12-10 | AA01 | accounts | Change account reference date company previous extended | |
| 2024-12-08 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-05-08 | TM01 | officers | Termination director company with name termination date | |
| 2024-04-29 | AA | accounts | Accounts with accounts type dormant | |
| 2024-03-01 | AA01 | accounts | Change account reference date company previous shortened | |
| 2023-11-28 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-03-31 | AP01 | officers | Appoint person director company with name date | |
| 2023-03-29 | MR01 | mortgage | Mortgage create with deed with charge number charge creation date | |
| 2023-03-21 | MR01 | mortgage | Mortgage create with deed with charge number charge creation date | |
| 2022-10-26 | NEWINC | incorporation | Incorporation company |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 2
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.
Year-on-year
FY2024 → FY2025 · period ending 2025-03-31 vs 2024-03-31
-
Turnover
-10.7%
£26,207,259 £23,402,882
-
Cash
—
Not reported
-
Net assets
-53.2%
-£14,282,368 -£21,877,148
lowest in 3 filed years
-
Employees
-21.8%
261 204
-
Operating profit
+63.3%
-£11,539,191 -£4,235,303
-
Profit before tax
+46.8%
-£14,282,369 -£7,594,780
-
Wages
-9.1%
£5,853,067 £5,319,362
Each % is (latest − prior) ÷ |prior| for the line item as filed. Periods don't have to be exactly 12 months apart — a long or short period (typical around incorporation or year-end changes) will distort the comparison. Lines a company doesn't report are omitted. About these numbers